Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year.

Effective January 18, 2022, Artivion, Inc., formerly known as CryoLife, Inc., a Delaware corporation (the "Company"), changed its corporate name from "CryoLife, Inc." to "Artivion, Inc." pursuant to a Certificate of Amendment (the "Certificate of Amendment") of the Certificate of Incorporation (as amended, the "Certificate of Incorporation"), which was filed with the Secretary of State of the State of Delaware (the "Name Change").

The Board of Directors of the Company (the "Board") approved the Name Change pursuant to Section 242 of the General Corporation Law of the State of Delaware. The Name Change does not affect the rights of the Company's stockholders, and there were no other changes to the Certificate of Incorporation. A copy of the Certificate of Amendment is attached hereto as Exhibit 3.1 and incorporated herein by reference.

The Board also approved an amendment and restatement of the Company's Bylaws (the "Bylaws") to reflect the Name Change (as amended and restated, the "Amended and Restated Bylaws"), effective January 18, 2022. There were no other changes to the Bylaws. A copy of the Amended and Restated Bylaws is attached hereto as Exhibit 3.2 and incorporated herein by reference.

In connection with the Name Change, the Company's ticker symbol will also change from "CRY" to "AORT" (the "Ticker Change"). Trading under the new ticker symbol on the New York Stock Exchange is anticipated to begin on January 24, 2022.

Item 8.01 Other Events.

On January 18, 2022, the Company issued a press release announcing the Company's Name Change and Ticker Change. A copy of the press release is furnished hereto as Exhibit 99.1 and incorporated herein by reference.

The information in Item 8.01 of this Current Report on Form 8-K, including the information in the press release attached hereto as Exhibit 99.1, is furnished pursuant to Item 8.01 of Form 8-K and shall not be deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section. Furthermore, the information in Item 8.01 of this Current Report on Form 8-K, including the information in the press release attached hereto as Exhibit 99.1, shall not be deemed to be incorporated by reference in the filings of the Company under the Securities Act of 1933, as amended.

Item 9.01 Financial Statements and Exhibits.




(d)Exhibits.

Exhibit Number         Description
  3.1            Certificate of Amendment
  3.2            Amended and Restated Bylaws
  99.1           Press Release, dated January 18, 2022
104              Cover Page Interactive Data File (formatted as Inline XBRL and
                 contained in Exhibit 101)



?

                                      -2-

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses